| 产品详情 |
| Edit |   |
|---|
| Product Name | PGP9.5, 1-223aa, Human, E Coli (Bioactivity Validated) |
|---|
| Description | MW: 24.8 kDa (223 aa), confirmed by MALDI-TOF. (Molecular weight on SDS-PAGE will appear higher). Purity >95% by SDS-PAGE. PGP9.5/uCH-L1 is a member of a gene family whose products hydrolyze small C-terminal adducts of ubiquitin to generate the ubiquitin monomer. PGP9.5 is a component of the ubiquitin system, which has a fundamental role in regulating various biological activities. PGP9.5 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disea |
|---|
| Size | 0.1 mg, 0.5 mg |
|---|
| Concentration | 1 mg/ml (determined by Bradford assay) |
|---|
| Applications | SDS-PAGE |
|---|
| Other Names | [ubiquitin carboxyl-terminal esterase L1; uCHL1; PGP9.5; 1-223aa; uCH-L1; EC 3.4.19.12; ubiquitin thioesterase L1; Neuron cytoplasmic protein 9.5; PGP 9.5; PGP9.5; ubiquitin carboxyl-terminal hydrolase isozyme L1; ubiquitin carboxyl-terminal esterase L1 Gracile axonal dystrophy; Neuron cytoplasmic protein 9.5; Park 5; Parkinson Disease 5; PGP95; uCH L1; Protein gene product 9.5; ubiquitin C terminal esterase L1; ubiquitin C terminal hydrolase (neuron specific); ubiquitin carboxyl terminal estera |
|---|
| Gene, Accession, CAS # | PGP9.5, Gene ID: 7345, Accession: NP_004172 |
|---|
| Catalog # | MBS203019 |
|---|
| Price | |
|---|
| Order / More Info | PGP9.5, 1-223aa, Human, E Coli (Bioactivity Validated) from MYBIOSOURCE INC. |
|---|
| Product Specific References | Sakurai M., et al. (2006) Cell 119, 162-171.; Liu Y., et al. (2002) Cell. 111 (2):209-18.; |
|---|
| 产品资料 |
|
|